Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis

Risk factors and treatment outcomes under program conditions for isoniazid (INH)-monoresistant tuberculosis have not been well described. Medical charts were retrospectively reviewed for all cases of culture-confirmed, INH-monoresistant tuberculosis ( n = 137) reported to the San Francisco Departmen...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Clinical infectious diseases Ročník 48; číslo 2; s. 179
Hlavní autori:	Cattamanchi, Adithya, Dantes, Raymund B, Metcalfe, John Z, Jarlsberg, Leah G, Grinsdale, Jennifer, Kawamura, L Masae, Osmond, Dennis, Hopewell, Philip C, Nahid, Payam
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 15.01.2009
Predmet:	Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Drug Resistance, Bacterial Female Humans Isoniazid - pharmacology Male Middle Aged Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - isolation & purification Pyrazinamide - adverse effects Pyrazinamide - therapeutic use San Francisco Treatment Outcome Tuberculosis - drug therapy Tuberculosis - microbiology Tuberculosis - physiopathology San Francisco
ISSN:	1537-6591, 1537-6591
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!